Business Description
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.38 | |||||
Debt-to-EBITDA | -0.82 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.81 | |||||
Beneish M-Score | -3.32 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 28.6 | |||||
3-Year EBITDA Growth Rate | -160.3 | |||||
3-Year EPS without NRI Growth Rate | -128.3 | |||||
3-Year FCF Growth Rate | -372.5 | |||||
3-Year Book Growth Rate | 10 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.44 | |||||
9-Day RSI | 38.64 | |||||
14-Day RSI | 38.15 | |||||
6-1 Month Momentum % | 26.65 | |||||
12-1 Month Momentum % | 79.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.63 | |||||
Quick Ratio | 2.73 | |||||
Cash Ratio | 1.98 | |||||
Days Inventory | 123.21 | |||||
Days Sales Outstanding | 77.47 | |||||
Days Payable | 39.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.4 | |||||
Shareholder Yield % | -1.47 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -24.35 | |||||
Operating Margin % | -136.53 | |||||
Net Margin % | -161.2 | |||||
FCF Margin % | -150.65 | |||||
ROE % | -148.07 | |||||
ROA % | -71.55 | |||||
ROIC % | -91.8 | |||||
ROC (Joel Greenblatt) % | -228.08 | |||||
ROCE % | -72.04 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10.34 | |||||
PB Ratio | 13.61 | |||||
Price-to-Tangible-Book | 56.57 | |||||
EV-to-EBIT | -7.56 | |||||
EV-to-EBITDA | -8.51 | |||||
EV-to-Revenue | 10.93 | |||||
EV-to-FCF | -7.84 | |||||
Price-to-Net-Current-Asset-Value | 13.2 | |||||
Earnings Yield (Greenblatt) % | -13.25 | |||||
FCF Yield % | -14.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BactiQuant AS Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 8.985 | ||
EPS (TTM) (kr) | -0.64 | ||
Beta | 1.93 | ||
Volatility % | 168.41 | ||
14-Day RSI | 38.15 | ||
14-Day ATR (kr) | 0.369238 | ||
20-Day SMA (kr) | 4.188 | ||
12-1 Month Momentum % | 79.78 | ||
52-Week Range (kr) | 2.18 - 13.5 | ||
Shares Outstanding (Mil) | 23.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BactiQuant AS Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BactiQuant AS Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
BactiQuant AS Frequently Asked Questions
What is BactiQuant AS(OCSE:BACTIQ)'s stock price today?
When is next earnings date of BactiQuant AS(OCSE:BACTIQ)?
Does BactiQuant AS(OCSE:BACTIQ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |